UNIGE document Scientific Article
previous document  unige:32665  next document
add to browser collection


Published in Revue médicale suisse. 2012, vol. 8, no. 324, p. 109-15
Abstract The results of the fracture risk assessment tool (FRAX) could be modulated. Calcium supplements are still in the middle of a cardiovascular controversy. New immunological properties of vitamin D are reported. Denosumab is effective for the prevention of all fractures and can be used without renal limitation. Atypical subtrochanteric femoral fractures are more frequent in case of treatment with bisphosphonates. The teriparatide is effective in various bone diseases. Bazedoxifene, a new SERM is now available. A meta-analysis fails to demonstrate the effectiveness of vertebroplasty on pain relief in case of osteoporotic vertebral fractures.
Keywords Antibodies, Monoclonal, Humanized/administration & dosage/adverse effectsBone Density Conservation Agents/administration & dosage/adverse effectsCalcium/administration & dosageDiphosphonates/administration & dosage/adverse effectsFemaleHumansIndoles/administration & dosage/adverse effectsOsteoporosis/prevention & controlOsteoporosis, Postmenopausal/prevention & controlOsteoporotic Fractures/prevention & controlRisk AssessmentTeriparatide/administration & dosage/adverse effectsTreatment OutcomeVitamin D/administration & dosage/adverse effects
PMID: 23185820
Full text
Article (Published version) (666 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Other version: http://rms.medhyg.ch/numero-324-page-109.htm
Research group Nutrition et os (66)
(ISO format)
UEBELHART, Brigitte Florence, RIZZOLI, René. Ostéoporose. In: Revue médicale suisse, 2012, vol. 8, n° 324, p. 109-15. https://archive-ouverte.unige.ch/unige:32665

384 hits

0 download


Deposited on : 2013-12-23

Export document
Format :
Citation style :